Natalizumab for keeping patients out of HARRMS way?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1644, 2008-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab for keeping patients out of HARRMS way?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 557, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis: What Drug and Which Way?

By Banerjee D.   Stableforth D.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1053-1064

Adis International

Access to resources Recommend Favorite

Natalizumab: Progressive multifocal leukoencephalopathy?: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite

Natalizumab: First report of morphoea?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1301, 2010-01 ,pp. : 37-37

Adis International

Access to resources Recommend Favorite

Immunosuppressants/natalizumab: Glioma?: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite